Relationship between elevated serum direct bilirubin and atrial fibrillation risk among patients with coronary artery

Yanbin Song1,2, Wenhua Li1,2

  • 1Department of Cardiology, Wujin Hospital Affiliated With Jiangsu University, Changzhou, China.

Frontiers in Medicine
|March 3, 2025
PubMed

Insights

Higher direct bilirubin (DBIL) levels are linked to increased atrial fibrillation (AF) risk in coronary artery disease (CAD) patients. This association is more pronounced in older individuals, those with lower BMI, and patients with diabetes mellitus.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Research

Background:

  • Observational studies indicate a correlation between direct bilirubin (DBIL) and metabolic syndrome/cardiovascular disease.
  • The specific association between DBIL and atrial fibrillation (AF) risk in patients with coronary artery disease (CAD) remains under investigation.

Purpose of the Study:

  • To investigate the relationship between serum DBIL levels and the incidence of AF in patients diagnosed with CAD.

Main Methods:

  • Retrospective analysis of 937 CAD patients, comparing serum DBIL and other biochemical markers between AF and non-AF groups.
  • Utilized univariate and multivariate logistic regression, alongside restricted cubic spline (RCS) regression, to analyze DBIL-AF association.
  • Participant characteristics were stratified by DBIL tertiles for comparative analysis.

Main Results:

  • A higher prevalence of AF was observed in patients with elevated DBIL levels (p < 0.001).
  • Patients in the highest DBIL tertile (T3) showed a significantly higher proportion of AF and lower levels of lipids, Apo B, and TyG compared to lower tertiles.
  • Multivariate logistic regression confirmed a significant association between higher DBIL levels and increased AF risk (adjusted OR: 2.239), with a nonlinear relationship identified by RCS analysis.

Conclusions:

  • Elevated serum DBIL levels are robustly associated with an increased risk of AF in patients with CAD.
  • The association between higher DBIL and AF risk is particularly significant in CAD patients aged ≥65 years, with a BMI < 25, and those with diabetes mellitus (DM).
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
248
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891